208 related articles for article (PubMed ID: 27941885)
21. DBC2 is essential for transporting vesicular stomatitis virus glycoprotein.
Chang FK; Sato N; Kobayashi-Simorowski N; Yoshihara T; Meth JL; Hamaguchi M
J Mol Biol; 2006 Dec; 364(3):302-8. PubMed ID: 17023000
[TBL] [Abstract][Full Text] [Related]
22. CGRRF1, a growth suppressor, regulates EGFR ubiquitination in breast cancer.
Lee YJ; Ho SR; Graves JD; Xiao Y; Huang S; Lin WC
Breast Cancer Res; 2019 Dec; 21(1):134. PubMed ID: 31801577
[TBL] [Abstract][Full Text] [Related]
23. WW domain-containing E3 ubiquitin protein ligase 1 targets p63 transcription factor for ubiquitin-mediated proteasomal degradation and regulates apoptosis.
Li Y; Zhou Z; Chen C
Cell Death Differ; 2008 Dec; 15(12):1941-51. PubMed ID: 18806757
[TBL] [Abstract][Full Text] [Related]
24. CHIP-mediated degradation of transglutaminase 2 negatively regulates tumor growth and angiogenesis in renal cancer.
Min B; Park H; Lee S; Li Y; Choi JM; Lee JY; Kim J; Choi YD; Kwon YG; Lee HW; Bae SC; Yun CO; Chung KC
Oncogene; 2016 Jul; 35(28):3718-28. PubMed ID: 26568304
[TBL] [Abstract][Full Text] [Related]
25. Mutation analysis of the 8p candidate tumour suppressor genes DBC2 (RHOBTB2) and LZTS1 in bladder cancer.
Knowles MA; Aveyard JS; Taylor CF; Harnden P; Bass S
Cancer Lett; 2005 Jul; 225(1):121-30. PubMed ID: 15922864
[TBL] [Abstract][Full Text] [Related]
26. Ubiquitination and downregulation of BRCA1 by ubiquitin-conjugating enzyme E2T overexpression in human breast cancer cells.
Ueki T; Park JH; Nishidate T; Kijima K; Hirata K; Nakamura Y; Katagiri T
Cancer Res; 2009 Nov; 69(22):8752-60. PubMed ID: 19887602
[TBL] [Abstract][Full Text] [Related]
27. WWP1 E3 ligase targets LATS1 for ubiquitin-mediated degradation in breast cancer cells.
Yeung B; Ho KC; Yang X
PLoS One; 2013; 8(4):e61027. PubMed ID: 23573293
[TBL] [Abstract][Full Text] [Related]
28. Stability of HIB-Cul3 E3 ligase adaptor HIB Is Regulated by Self-degradation and Availability of Its Substrates.
Zhou Z; Xu C; Chen P; Liu C; Pang S; Yao X; Zhang Q
Sci Rep; 2015 Aug; 5():12709. PubMed ID: 26263855
[TBL] [Abstract][Full Text] [Related]
29. Tumor-suppressor role for the SPOP ubiquitin ligase in signal-dependent proteolysis of the oncogenic co-activator SRC-3/AIB1.
Li C; Ao J; Fu J; Lee DF; Xu J; Lonard D; O'Malley BW
Oncogene; 2011 Oct; 30(42):4350-64. PubMed ID: 21577200
[TBL] [Abstract][Full Text] [Related]
30. The atypical Rho GTPase RhoBTB2 is required for expression of the chemokine CXCL14 in normal and cancerous epithelial cells.
McKinnon CM; Lygoe KA; Skelton L; Mitter R; Mellor H
Oncogene; 2008 Nov; 27(54):6856-65. PubMed ID: 18762809
[TBL] [Abstract][Full Text] [Related]
31. DBC2, a candidate for a tumor suppressor gene involved in breast cancer.
Hamaguchi M; Meth JL; von Klitzing C; Wei W; Esposito D; Rodgers L; Walsh T; Welcsh P; King MC; Wigler MH
Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13647-52. PubMed ID: 12370419
[TBL] [Abstract][Full Text] [Related]
32. RING finger protein 31 promotes p53 degradation in breast cancer cells.
Zhu J; Zhao C; Zhuang T; Jonsson P; Sinha I; Williams C; Strömblad S; Dahlman-Wright K
Oncogene; 2016 Apr; 35(15):1955-64. PubMed ID: 26148235
[TBL] [Abstract][Full Text] [Related]
33. BCAS3 exhibits oncogenic properties by promoting CRL4A-mediated ubiquitination of p53 in breast cancer.
Zhou Z; Qiu R; Liu W; Yang T; Li G; Huang W; Teng X; Yang Y; Yu H; Yang Y; Wang Y
Cell Prolif; 2021 Aug; 54(8):e13088. PubMed ID: 34240781
[TBL] [Abstract][Full Text] [Related]
34. Post-translational modification of OCT4 in breast cancer tumorigenesis.
Cho Y; Kang HG; Kim SJ; Lee S; Jee S; Ahn SG; Kang MJ; Song JS; Chung JY; Yi EC; Chun KH
Cell Death Differ; 2018 Nov; 25(10):1781-1795. PubMed ID: 29511337
[TBL] [Abstract][Full Text] [Related]
35. TAZ antagonizes the WWP1-mediated KLF5 degradation and promotes breast cell proliferation and tumorigenesis.
Zhao D; Zhi X; Zhou Z; Chen C
Carcinogenesis; 2012 Jan; 33(1):59-67. PubMed ID: 22045023
[TBL] [Abstract][Full Text] [Related]
36. Musashi-2 is a novel regulator of paclitaxel sensitivity in ovarian cancer cells.
Lee J; An S; Choi YM; Lee J; Ahn KJ; Lee JH; Kim TJ; An IS; Bae S
Int J Oncol; 2016 Nov; 49(5):1945-1952. PubMed ID: 27600258
[TBL] [Abstract][Full Text] [Related]
37. DBC2 gene is silenced by promoter methylation in bladder cancer.
Shi Y; Chen JY; Yang J; Li B; Chen ZH; Xiao CG
Urol Oncol; 2008; 26(5):465-9. PubMed ID: 18640857
[TBL] [Abstract][Full Text] [Related]
38. Loss of DBC2 expression is an early and progressive event in the development of lung adenocarcinoma.
Dong W; Meng L; Shen HC; Du JJ
Asian Pac J Cancer Prev; 2012; 13(5):2021-3. PubMed ID: 22901165
[TBL] [Abstract][Full Text] [Related]
39. KLHL39 suppresses colon cancer metastasis by blocking KLHL20-mediated PML and DAPK ubiquitination.
Chen HY; Hu JY; Chen TH; Lin YC; Liu X; Lin MY; Lang YD; Yen Y; Chen RH
Oncogene; 2015 Oct; 34(40):5141-51. PubMed ID: 25619834
[TBL] [Abstract][Full Text] [Related]
40. HUWE1 interacts with BRCA1 and promotes its degradation in the ubiquitin-proteasome pathway.
Wang X; Lu G; Li L; Yi J; Yan K; Wang Y; Zhu B; Kuang J; Lin M; Zhang S; Shao G
Biochem Biophys Res Commun; 2014 Feb; 444(3):290-5. PubMed ID: 24342616
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
